According to foreign media reports, when Mitch Zeller retired in April, the FDA's Center for Tobacco Products appointed current CTP Deputy Director Michele Mital as acting director. The agency is currently searching for a permanent director.
On March 31, 2022, FDA Tracker reported on this news for the first time in a tweet, and received confirmation from Filter reporter Alex Norcia after speaking with FDA officials. An official announcement has not yet been released.
According to a paid report by ECig Intelligence on March 25th, Mital is the most likely candidate to take on the permanent position, although other applications are still under review. ECig Intelligence suggests that with her 25-year history at the organization, she is considered as "safe hands.
Whoever is appointed as a permanent director must receive approval from newly-appointed FDA commissioner Robert Califf and Department of Health and Human Services secretary Xavier Becerra, both of whom are skeptical and hostile towards e-cigarettes. In recent years, both have advocated for a complete ban of flavored products.
Mital joined the FDA in 1996 and has served in multiple positions, including in the legislative office. Since the establishment of CTP in 2009, Mital has worked there in various capacities, and was appointed Deputy Director in 2018.
Mitch Zeller has been serving as the director of the Center for Tobacco Products (CTP) since 2013, making him the second person to hold the position since the CTP was established in 2009. He has led the organization as it granted itself regulatory authority over electronic cigarettes under the estimated rules of 2016, and oversaw the implementation of a chaotic pre-market review process.
After a year-long review of Pre-Market Tobacco Applications (PMTAs), the agency issued millions of standardized marketing denial orders (MDOs) to hundreds of small e-cigarette manufacturers, effectively eliminating over 99% of the legal e-cigarette market. The FDA is now facing dozens of legal challenges from independent e-cigarette manufacturers, and has been forced to rescind some MDOs while others are pending in federal court.
Since the submission deadline for Pre-Market Tobacco Product Applications (PMTA) in September 2020, the agency has only authorized three types of electronic cigarette devices.
(Source: Vaping360)
The Deputy Director of the Center for Tobacco Products (CTP) will act as the interim Director when the current Director, Zeller, retires. This move was announced in the vaping industry news platform, Vaping360.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
